Stock Markets: Nasdaq

Remetinostat Phase II Data Demonstrate Efficacy on Skin Lesions, Reduction of Itching and High Tolerability in Patients With Early-stage MF-type CTCL

These data were contained in an abstract published at the European Organization for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force meeting being held in London on October 13-15th. The details of the study are scheduled to be presented at the meeting by Dr Madeleine Duvic, Professor of Internal Medicine and Dermatology at the MD Anderson Cancer Center in Houston, Texas. The remetinostat phase II trial enrolled 60 patients with stage IA-IIA MF, the predominant variant...

Published on .

Biostage to Move to OTCQB Marketplace

As previously disclosed, on November 18, 2016, the Company received a notice from NASDAQ indicating it was not in compliance with NASDAQ’s minimum bid price requirement, and on May 22, 2017, NASDAQ notified the Company that based noncompliance with that rule and with the $2.5 million minimum stockholders equity requirement, the Company’s common stock would be subject to delisting.  The Company requested a hearing with the Panel and, on July 10, 2017, the Company announced that the Panel granted...

Published on .

Stock Performance Review on REIT Industry — Independence Realty Trust, AGNC Investment, American Campus Communities, and Mid-America Apartment Communities

If you want a Stock Review on IRT, AGNC, ACC, or MAA then come over to http://dailystocktracker.com/register/ and sign up for your free customized report. On Thursday, the NASDAQ Composite ended the day at 6,585.36, up 0.78%; the Dow Jones Industrial Average edged 0.50% higher, to finish at 22,775.39; and the S&P 500 closed at 2,552.07, marginally gaining 0.56%. Gains were broad based as seven...

Published on .

NXT-ID COO and Fit Pay President, Michael Orlando to be a Featured Speaker at Secure Technology Alliance’s IoT Payments 2017 Conference

IoT Payments 2017, which takes place October 10-11, 2017 at the Hyatt Regency in Austin, Texas, will bring together experts from both the IoT and payments communities to discuss the most important developments, innovations and efforts driving secure, seamless IoT payments. The event is organized by the Secure Technology Alliance (formerly the Smart Card Alliance), a not-for-profit, multi-industry association working to stimulate the understanding, adoption and widespread application of secure...

Published on .

CME Group Reached Average Daily Volume of 17 Million Contracts in September 2017, up 13 Percent from September 2016

Metals volume averaged 660,000 contracts per day in September 2017, up 72 percent from September 2016.  Highlights include: Reached record quarterly ADV of 611,000 contracts, up 42 percent from third-quarter 2016, including records for Gold, Copper and Platinum futures and options Grew Gold futures and options ADV 86 percent to 418,000 contracts, including record monthly Gold futures...

Published on .

Aethlon Medical Receives National Cancer Institute Contract Award

The NCI Phase I contract period runs from September 15, 2017 and runs through June 14, 2018.  The total amount of the firm fixed price contract is $299,250.  The contract calls for two subcontractors to work with the Company. The subcontractors under Aethlon Medical on the contract are University of Pittsburgh and Massachusetts General Hospital. Aethlon Medical is investigating the potential use of the Aethlon Hemopurifier® to reduce the presence of circulating tumor-derived exosomes...

Published on .

Idera Pharmaceuticals Presents Positive Phase 1 Data for Intratumoral IMO-2125 in Combination with Ipilimumab Demonstrating an Overall Response Rate (ORR) of 44% in Melanoma Patients Refractory to Anti-PD1 Therapy

CAMBRIDGE, Mass. and EXTON, Pa., Sept. 10, 2017 — Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), a clinical-stage biopharmaceutical company developing toll-like receptor and RNA therapeutics for patients with rare cancers and rare diseases, today announced final results from the dose-selection phase of an ongoing Phase 1/2 trial investigating IMO-2125, Idera’s intratumorally-delivered Toll-like Receptor (TLR) 9 agonist, in combination with ipilimumab (Yervoy®), manufactured by Bristol-Myers...

Published on .

Magic Announces Distribution of Cash Dividend for First Half of 2017

The dividend is payable on September 13, 2017 to all of the Company’s shareholders of record at the close of the NASDAQ Global Select Market on August 29, 2017. In accordance with Israeli tax law, the dividend is subject to withholding tax at source at the rate of 30% (if the recipient of the dividend is at the time of distribution or was at any time during the preceding 12-month period the holder of 10% or more of the Company’s share capital) or 25% (for all other dividend recipients)...

Published on .

Magic Increases its Dividend Policy From 50% to 75% of its Annual Distributable Profits

According to the Company’s amended policy, each year the Company will distribute a dividend of up to 75% of its annual distributable profits. The Company’s Board of Directors may at its discretion and at any time, change, whether as a result of a one-time decision or a change in policy, the rate of dividend distributions and/or decide not to distribute a dividend, all at its discretion. The actual distribution of a dividend will be subject to meeting the conditions required by applicable...

Published on .

Supermicro prevé un sistema NVMe en 1U con capacidad de petabytes compatible con las unidades SSD de “regla” de Intel®

SAN JOSÉ, California, 9 de agosto de 2017 — Super Micro Computer, Inc. (NASDAQ: SMCI), un líder mundial en las tecnologías de computación, almacenamiento y redes, y que también incluyen la computación verde, presentará su sistema all-flash NVMe (Non-Volatile Memory Express) con capacidad de petabytes en la Cumbre de Memorias Flash (FMS 2017) que se celebrará en el Centro de Convenciones de Santa Clara (California) del 8 al 10 de agosto de 2017. Con un total...

Published on .

HD SUPPLY SHAREHOLDER ALERT: CLAIMSFILER Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against HD Supply Holdings, Inc. – (HDS)

HD Supply Holdings investors should visit us at https://www.claimsfiler.com/cases/nasdaq-hds or call to speak to our claim center toll-free at (844) 367-9658. About the Lawsuit HD Supply Holdings and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.  The alleged false and...

Published on .